Privia Health Group (NASDAQ:PRVA) Given New $21.00 Price Target at Barclays

Privia Health Group (NASDAQ:PRVAFree Report) had its target price upped by Barclays from $19.00 to $21.00 in a research report released on Friday morning,Benzinga reports. The firm currently has an equal weight rating on the stock.

Other analysts have also issued research reports about the stock. Robert W. Baird raised their price target on shares of Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a research report on Monday, August 26th. KeyCorp initiated coverage on shares of Privia Health Group in a report on Friday, October 11th. They set an “overweight” rating and a $23.00 price objective on the stock. Royal Bank of Canada reaffirmed an “outperform” rating and set a $28.00 price objective on shares of Privia Health Group in a report on Wednesday, August 14th. Finally, Truist Financial increased their price objective on shares of Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a report on Friday. Two analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $25.07.

Check Out Our Latest Research Report on PRVA

Privia Health Group Stock Performance

PRVA stock opened at $22.80 on Friday. The firm has a market cap of $2.73 billion, a PE ratio of 228.00, a P/E/G ratio of 4.84 and a beta of 0.76. The firm’s fifty day moving average is $18.48 and its 200 day moving average is $18.39. Privia Health Group has a one year low of $15.92 and a one year high of $24.35.

Insider Transactions at Privia Health Group

In other news, CEO Parth Mehrotra sold 135,142 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total value of $2,500,127.00. Following the transaction, the chief executive officer now directly owns 247,771 shares of the company’s stock, valued at approximately $4,583,763.50. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Insiders own 14.20% of the company’s stock.

Hedge Funds Weigh In On Privia Health Group

A number of institutional investors have recently bought and sold shares of PRVA. First Light Asset Management LLC purchased a new position in Privia Health Group during the first quarter worth about $21,620,000. Millennium Management LLC increased its position in shares of Privia Health Group by 2,994.2% during the second quarter. Millennium Management LLC now owns 1,138,526 shares of the company’s stock valued at $19,788,000 after acquiring an additional 1,101,730 shares during the last quarter. BlackBarn Capital Partners LP increased its position in shares of Privia Health Group by 100.0% during the second quarter. BlackBarn Capital Partners LP now owns 400,000 shares of the company’s stock valued at $6,952,000 after acquiring an additional 200,000 shares during the last quarter. Dimensional Fund Advisors LP increased its position in shares of Privia Health Group by 18.4% during the second quarter. Dimensional Fund Advisors LP now owns 1,118,619 shares of the company’s stock valued at $19,441,000 after acquiring an additional 173,934 shares during the last quarter. Finally, Sei Investments Co. increased its position in shares of Privia Health Group by 50.7% during the first quarter. Sei Investments Co. now owns 457,880 shares of the company’s stock valued at $8,970,000 after acquiring an additional 154,044 shares during the last quarter. 94.48% of the stock is owned by hedge funds and other institutional investors.

Privia Health Group Company Profile

(Get Free Report)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

See Also

Analyst Recommendations for Privia Health Group (NASDAQ:PRVA)

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.